YARNO WENDY L 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Jun 16, 2026
Research Summary
AI-generated summary of this filing
Tarsus (TARS) Director Wendy L. Yarno Receives 2,954 RSU Shares
What Happened
Wendy L. Yarno, a director of Tarsus Pharmaceuticals (TARS), had 2,954 Restricted Stock Units (RSUs vest) converted into 2,954 shares on 2026-06-12. The Form 4 shows an acquisition of 2,954 shares pursuant to settlement of vested RSUs and a simultaneous disposition of 2,954 shares at $0.00. The report lists the acquisition price as N/A and the disposition proceeds as $0, indicating no cash sale in the open market.
Key Details
- Transaction date: 2026-06-12; Form 4 filed 2026-06-16 (filed within required period).
- Acquired: 2,954 shares via settlement of vested RSUs (reported as conversion of derivative).
- Disposed: 2,954 shares at $0.00 (same number as acquired).
- Reported values: acquisition price N/A; disposition proceeds $0.
- Footnotes: RSUs were granted on June 12, 2025 for non-employee director service and vested in full on the one-year anniversary (per filing).
- Net change in beneficial ownership from these entries: 0 shares (2,954 acquired and 2,954 disposed).
- Shares owned after transaction: not specified in the provided excerpt.
Context
- This is a routine settlement of director RSUs, not an open-market purchase or sale. The paired acquisition and $0 disposition typically reflect shares issued on vesting with an equal number withheld or surrendered to satisfy tax withholding obligations (common practice), rather than a market sale.
- Such award settlements are compensation-related and do not necessarily signal insider confidence or a change in investment view.
Insider Transaction Report
Form 4
YARNO WENDY L
Director
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-06-12+2,954→ 16,654 total - Exercise/Conversion
Restricted Stock Units
[F2][F3]2026-06-12−2,954→ 0 total→ Common Stock (2,954 underlying)
Footnotes (3)
- [F1]The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.
- [F2]Each RSU represents a contingent right to receive one share of the Company's common stock.
- [F3]RSUs granted on June 12, 2025, in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
Signature
/s/ Jeffrey Farrow, Attorney-in-Fact|2026-06-16